证券记录 · 已归档季度
BEAM
Beam Therapeutics Inc. · Healthcare · Biotechnology
13被追踪持有人
+2Δ持有人
16.59M持有股份
$411.47M报告持仓市值
+3新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +18.2% ·
股份流向 +10.8% ·
净新建仓位 +15.4%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +9 | 71.47M | $2.45B | +12 | −3 |
| Q1 2026 | 92 | +3 | 70.17M | $1.67B | +9 | −6 |
| Q4 2025 | 89 | +3 | 73.41M | $2.04B | +4 | −1 |
| Q3 2025 | 16 | -1 | 52.77M | $1.28B | +1 | −2 |
| Q2 2025 | 14 | 0 | 51.27M | $872.17M | +1 | −1 |
| Q1 2025 | 11 | -2 | 20.67M | $403.69M | — | −2 |
| Q4 2024 | 13 | +2 | 16.59M | $411.47M | +3 | −1 |
| Q3 2024 | 10 | -1 | 11.89M | $291.41M | — | −1 |
| Q2 2024 | 11 | — | 12.82M | $300.27M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 7.07M | +8.2% | $175.29M | 1.5% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 3.08M | — | $76.32M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.06M | +37.8% | $51.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.06M | +37.8% | $51.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.80M | -0.2% | $44.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 1.80M | -0.2% | $44.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 1.75M | +17.9% | $43.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 1.75M | +17.9% | $43.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 193.36K | 新增 | $4.80M | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 117.09K | +75.2% | $2.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 75.35K | -7.8% | $1.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 55.00K | 新增 | $1.36M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 55.00K | 新增 | $1.36M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 22.91K | 新增 | $568,094 | 0.0% | New | 1 | SEC ↗ |
| 22 | Norges Bank ✦ (被动) | 18.59K | 0.0% | $461,057 | 0.0% | Held | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $4.80M | 0.0% |
| Marshall Wace | $1.36M | 0.0% |
| Marshall Wace | $1.36M | 0.0% |
| Renaissance Technologies | $568,094 | 0.0% |
已清仓
| AQR Capital Management | $216,629 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 248 持有人, 107.79M 股份, $2.49B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据